Skip to main content

Assessment of ARIA Sufficiency: Bimzelx (bimekizumab-bkzx)

    Basic Details
    Approval Date
    Tuesday, October 17, 2023
    Original Posting Date
    Health Outcome(s)
    adverse pregnancy and fetal outcomes
    hepatitis B reactivation
    malignancy
    opportunistic infections
    serious infections
    tuberculosis (TB)